General Hospital of San Juan del Río, Querétaro, México.
Department of Intensive Care Medicine, Kings's College, London, UK.
Anaesthesiol Intensive Ther. 2021;53(2):162-178. doi: 10.5114/ait.2021.105252.
Critically ill patients are often presumed to be in a state of "constant dehydration" or in need of fluid, thereby justifying a continuous infusion with some form of intravenous (IV) fluid, despite their clinical data suggesting otherwise. Overzealous fluid administration and subsequent fluid accumulation and overload are associated with poorer outcomes. Fluids are drugs, and their use should be tailored to meet the patient's individualized needs; fluids should never be given as routine maintenance unless indicated. Before prescribing any fluids, the physician should consider the patient's characteristics and the nature of the illness, and assess the risks and benefits of fluid therapy. Decisions regarding fluid therapy present a daily challenge in many hospital departments: emergency rooms, regular wards, operating rooms, and intensive care units. Traditional fluid prescription is full of paradigms and unnecessary routines as well as malpractice in the form of choosing the wrong solutions for maintenance or not meeting daily requirements. Prescribing maintenance fluids for patients on oral intake will lead to fluid creep and fluid overload. Fluid overload, defined as a 10% increase in cumulative fluid balance from baseline weight, is an independent predictor for morbidity and mortality, and thus hospital cost. In the last decade, increasing evidence has emerged supporting a restrictive fluid approach. In this manuscript, we aim to provide a pragmatic description of novel concepts related to the use of IV fluids in critically ill patients, with emphasis on the different indications and common clinical scenarios. We also discuss active deresuscitation, or the timely cessation of fluid administration, with the intention of achieving a zero cumulative fluid balance.
危重症患者通常被认为处于“持续脱水”状态或需要补液,因此,尽管其临床数据表明并非如此,仍会持续输注某种形式的静脉(IV)补液。过度补液和随后的液体蓄积和超负荷与较差的预后相关。液体是药物,其使用应根据患者的个体需求进行调整;除非有指征,否则不应常规给予补液。在开具任何补液之前,医生应考虑患者的特征和疾病性质,并评估液体治疗的风险和益处。液体治疗的决策在许多医院科室(急诊科、普通病房、手术室和重症监护病房)每天都面临挑战。传统的液体处方充满了范例和不必要的常规,以及选择错误的维持解决方案或未能满足日常需求的医疗事故。对口服摄入的患者开具维持性补液会导致液体蓄积和液体超负荷。液体超负荷定义为从基线体重开始累积液体平衡增加 10%,是发病率和死亡率以及因此住院费用的独立预测因素。在过去十年中,越来越多的证据支持限制性液体治疗方法。在本文中,我们旨在提供一种实用的描述,介绍与危重症患者使用 IV 液体相关的新概念,重点介绍不同的适应证和常见临床情况。我们还讨论了主动复苏限制,即及时停止液体输注,以期实现零累积液体平衡。